Ligand source activities (1 row/activity)





Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Potency)
# tested GPCRs
(Potency)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
162644596 178839 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
CHEMBL4740228 178839 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
153585580 178864 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 411 6 1 8 1.7 COc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
CHEMBL4740491 178864 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 411 6 1 8 1.7 COc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
153585418 178867 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 434 5 1 8 1.4 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4740519 178867 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 434 5 1 8 1.4 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
148659040 178984 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 388 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(Br)n3c2=O)cc1 nan
CHEMBL4741806 178984 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 388 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(Br)n3c2=O)cc1 nan
153585598 179035 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 446 5 1 7 1.9 C[C@H](NC(=O)Cn1nc2cccc(N3CCN(C)CC3)n2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4742673 179035 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 446 5 1 7 1.9 C[C@H](NC(=O)Cn1nc2cccc(N3CCN(C)CC3)n2c1=O)c1ccc(Cl)c(F)c1 nan
148397968 179055 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
CHEMBL4742901 179055 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
147048009 179077 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 388 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(Br)cn3c2=O)cc1 nan
CHEMBL4743199 179077 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 388 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(Br)cn3c2=O)cc1 nan
147451915 179107 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 348 4 1 5 2.2 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4743612 179107 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 348 4 1 5 2.2 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(F)c1 nan
152956498 179130 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 324 4 1 5 2.2 Cc1ccc([C@H](C)NC(=O)C(C)n2nc3ccccn3c2=O)cc1 nan
CHEMBL4743938 179130 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 324 4 1 5 2.2 Cc1ccc([C@H](C)NC(=O)C(C)n2nc3ccccn3c2=O)cc1 nan
153585490 179161 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ncccn2c1=O nan
CHEMBL4744169 179161 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ncccn2c1=O nan
153585688 179178 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4744340 179178 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162647825 179255 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
CHEMBL4745096 179255 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
152005060 179282 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 447 5 1 8 1.3 C[C@H](NC(=O)Cn1nc2c(N3CCN(C)CC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4745432 179282 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 447 5 1 8 1.3 C[C@H](NC(=O)Cn1nc2c(N3CCN(C)CC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
150944515 179284 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 425 5 2 7 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(NC(=O)OC(C)(C)C)cccn3c2=O)cc1 nan
CHEMBL4745487 179284 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 425 5 2 7 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(NC(=O)OC(C)(C)C)cccn3c2=O)cc1 nan
147626442 179299 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1cn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2cn1 nan
CHEMBL4745668 179299 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1cn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2cn1 nan
150995037 179339 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cnccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4746108 179339 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cnccn2c1=O)c1ccc(Cl)c(F)c1 nan
162648023 179395 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 452 7 2 9 1.5 C[C@H](NC(=O)Cn1nc2c(NC3COC3)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4746822 179395 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 452 7 2 9 1.5 C[C@H](NC(=O)Cn1nc2c(NC3COC3)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585512 179448 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 367 4 1 6 1.7 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4747431 179448 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 367 4 1 6 1.7 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(Cl)c(F)c1 nan
162650006 179545 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2cccnn2c1=O nan
CHEMBL4748681 179545 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2cccnn2c1=O nan
153585452 179631 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4749705 179631 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(Cl)cc1 nan
151976938 179660 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
CHEMBL4750143 179660 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
147634500 179698 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ncc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1F nan
CHEMBL4750692 179698 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ncc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1F nan
149094095 179702 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 421 6 1 7 2.5 C[C@H](NC(=O)Cn1nc2ccc(C3CC3)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4750718 179702 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 421 6 1 7 2.5 C[C@H](NC(=O)Cn1nc2ccc(C3CC3)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
152023194 179750 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(Cl)cccn3c2=O)cc1 nan
CHEMBL4751203 179750 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(Cl)cccn3c2=O)cc1 nan
153585601 179757 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 478 6 1 8 2.0 C[C@H](NC(=O)Cn1nc2cccc(N3CCN(C)CC3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4751259 179757 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 478 6 1 8 2.0 C[C@H](NC(=O)Cn1nc2cccc(N3CCN(C)CC3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585718 179761 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2cc(C#N)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4751304 179761 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2cc(C#N)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585541 179800 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 341 5 1 7 1.1 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc2n1 nan
CHEMBL4751720 179800 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 341 5 1 7 1.1 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc2n1 nan
153585550 179812 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(C2CC2)c(F)c1 nan
CHEMBL4751886 179812 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(C2CC2)c(F)c1 nan
153585655 179894 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 493 7 1 8 2.9 COC1CCN(c2ccn3c(=O)n(CC(=O)N[C@@H](C)c4ccc(OC(F)(F)F)cc4)nc3c2)CC1 nan
CHEMBL4752993 179894 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 493 7 1 8 2.9 COC1CCN(c2ccn3c(=O)n(CC(=O)N[C@@H](C)c4ccc(OC(F)(F)F)cc4)nc3c2)CC1 nan
147378727 179945 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 6 1 6 2.1 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)c(F)c1 nan
CHEMBL4753547 179945 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 6 1 6 2.1 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)c(F)c1 nan
162653797 179948 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1F nan
CHEMBL4753587 179948 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1F nan
150050373 180013 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 339 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(C)nc(C)n3c2=O)cc1 nan
CHEMBL4754384 180013 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 339 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(C)nc(C)n3c2=O)cc1 nan
149101043 180021 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4754476 180021 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585478 180023 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4754503 180023 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585445 180175 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 382 4 1 5 2.5 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4756137 180175 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 382 4 1 5 2.5 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(C(F)(F)F)cc1 nan
153585588 180204 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 444 5 2 7 1.7 C[C@H](NC(=O)Cn1nc2c(N3CCC34CNC4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756392 180204 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 444 5 2 7 1.7 C[C@H](NC(=O)Cn1nc2c(N3CCC34CNC4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585712 180209 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 419 6 2 7 2.0 C[C@H](NC(=O)Cn1nc2cc(NC3COC3)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756431 180209 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 419 6 2 7 2.0 C[C@H](NC(=O)Cn1nc2cc(NC3COC3)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
94095050 180229 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 5 1 6 2.3 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4756787 180229 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 5 1 6 2.3 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585575 180247 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 433 5 2 8 1.0 C[C@H](NC(=O)Cn1nc2c(N3CCNCC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756937 180247 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 433 5 2 8 1.0 C[C@H](NC(=O)Cn1nc2c(N3CCNCC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
162656575 180301 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)c(F)c1 nan
CHEMBL4757480 180301 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)c(F)c1 nan
153585415 180306 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ncccn2c1=O nan
CHEMBL4757506 180306 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ncccn2c1=O nan
162656504 180314 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4757619 180314 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585404 180326 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
CHEMBL4757742 180326 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
149421402 180374 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 452 7 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(OC3COC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4758375 180374 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 452 7 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(OC3COC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162657688 180473 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)ccc1Cl nan
CHEMBL4759611 180473 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)ccc1Cl nan
153585534 180502 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 413 5 1 7 2.1 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)c(F)c3)c(=O)n2c1 nan
CHEMBL4759991 180502 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 413 5 1 7 2.1 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)c(F)c3)c(=O)n2c1 nan
162657416 180538 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
CHEMBL4760528 180538 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
153585663 180573 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1Cl nan
CHEMBL4760812 180573 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1Cl nan
153585574 180639 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 C[C@H](NC(=O)[C@@H](C)n1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4761321 180639 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 C[C@H](NC(=O)[C@@H](C)n1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
162660420 180693 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 5 1 6 2.0 CC[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4762121 180693 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 5 1 6 2.0 CC[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
147987797 180702 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4762206 180702 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(C(F)(F)F)cc1 nan
153585643 180759 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 5 1 7 1.7 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4762957 180759 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 5 1 7 1.7 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
147323186 180802 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 1 6 1.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3cnc(C)cn3c2=O)cc1 nan
CHEMBL4763362 180802 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 1 6 1.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3cnc(C)cn3c2=O)cc1 nan
153585610 180863 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ccccn2c1=O nan
CHEMBL4764290 180863 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ccccn2c1=O nan
162661581 180882 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 4 1 5 2.7 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ccccn2c1=O nan
CHEMBL4764506 180882 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 4 1 5 2.7 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ccccn2c1=O nan
153585681 180901 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4764666 180901 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
152494840 180915 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC(O)CC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4764839 180915 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC(O)CC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
134043805 181187 1 None 3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 6 1 6 2.0 CC(NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4777673 181187 1 None 3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 6 1 6 2.0 CC(NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)cc1 nan
162665057 181484 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4781404 181484 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(Cl)c1 nan
149618414 181679 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 2 6 1.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(N)cccn3c2=O)cc1 nan
CHEMBL4783739 181679 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 2 6 1.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(N)cccn3c2=O)cc1 nan
153585453 181686 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 431 6 1 7 2.6 C[C@H](NC(=O)Cn1nc2c(C(F)F)nccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4783815 181686 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 431 6 1 7 2.6 C[C@H](NC(=O)Cn1nc2c(C(F)F)nccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585542 181724 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4784153 181724 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
151570395 181805 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 340 5 1 6 1.7 COc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)n2c1 nan
CHEMBL4785283 181805 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 340 5 1 6 1.7 COc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)n2c1 nan
153585417 181845 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1Cl nan
CHEMBL4785963 181845 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1Cl nan
162667558 181880 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 331 4 1 6 1.4 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4786371 181880 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 331 4 1 6 1.4 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)cc1 nan
153585609 181890 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 465 6 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4786573 181890 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 465 6 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
151394869 181954 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4787308 181954 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
151043804 182093 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4789123 182093 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
162670176 182169 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 377 5 1 6 2.2 CC(C)[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4790080 182169 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 377 5 1 6 2.2 CC(C)[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
150234341 182208 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1ccnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 nan
CHEMBL4790498 182208 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1ccnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 nan
149881970 182272 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2n1 nan
CHEMBL4791551 182272 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2n1 nan
149784975 182296 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccncn3c2=O)cc1 nan
CHEMBL4791843 182296 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccncn3c2=O)cc1 nan
162670473 182328 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2c1 nan
CHEMBL4792356 182328 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2c1 nan
153585679 182341 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1F nan
CHEMBL4792515 182341 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1F nan
162671011 182362 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n2n1 nan
CHEMBL4792732 182362 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n2n1 nan
153585435 182412 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 359 4 1 6 2.0 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)nc2n1 nan
CHEMBL4793463 182412 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 359 4 1 6 2.0 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)nc2n1 nan
153585524 182548 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(F)cccn3c2=O)cc1 nan
CHEMBL4795078 182548 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(F)cccn3c2=O)cc1 nan
153585386 182651 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2ccc(Cl)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4796254 182651 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2ccc(Cl)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585438 182778 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2c1 nan
CHEMBL4797724 182778 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2c1 nan
153585532 182810 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(F)n3c2=O)cc1 nan
CHEMBL4798029 182810 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(F)n3c2=O)cc1 nan
162675990 182836 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 375 5 1 6 2.0 O=C(Cn1nc2cccnn2c1=O)N[C@H](c1ccc(Cl)c(F)c1)C1CC1 nan
CHEMBL4798509 182836 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 375 5 1 6 2.0 O=C(Cn1nc2cccnn2c1=O)N[C@H](c1ccc(Cl)c(F)c1)C1CC1 nan
153585488 182885 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
CHEMBL4799144 182885 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
153585707 182996 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 361 5 1 7 1.4 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)nc2n1 nan
CHEMBL4800487 182996 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 361 5 1 7 1.4 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)nc2n1 nan
153585650 178824 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 5 1 7 1.7 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4740004 178824 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 5 1 7 1.7 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162644596 178839 0 None 1 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
CHEMBL4740228 178839 0 None 1 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
162648528 179234 0 None 1 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 337 5 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)cc1 nan
CHEMBL4744984 179234 0 None 1 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 337 5 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)cc1 nan
146867363 179296 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 465 7 1 8 2.0 C[C@H](NC(=O)Cn1nc2cc(OC3CN(C)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4745642 179296 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 465 7 1 8 2.0 C[C@H](NC(=O)Cn1nc2cc(OC3CN(C)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162649809 179465 0 None 1 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 458 5 1 7 2.1 C[C@H](NC(=O)Cn1nc2c(N3CCC34CN(C)C4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4747632 179465 0 None 1 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 458 5 1 7 2.1 C[C@H](NC(=O)Cn1nc2c(N3CCC34CN(C)C4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585543 179656 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1 nan
CHEMBL4750043 179656 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1 nan
153585514 179792 0 None -10 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1 nan
CHEMBL4751629 179792 0 None -10 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1 nan
153585659 180050 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 6 1 7 1.5 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(OC(F)F)c(F)c1 nan
CHEMBL4754933 180050 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 6 1 7 1.5 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(OC(F)F)c(F)c1 nan
153585592 180161 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 464 6 2 8 1.7 C[C@H](NC(=O)Cn1nc2cccc(N3CCNCC3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4755986 180161 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 464 6 2 8 1.7 C[C@H](NC(=O)Cn1nc2cccc(N3CCNCC3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
133916051 180667 1 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 356 5 1 5 2.4 O=C(Cn1nc2ccccn2c1=O)NC(c1ccc(Cl)cc1)C1CC1 nan
CHEMBL4761733 180667 1 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 356 5 1 5 2.4 O=C(Cn1nc2ccccn2c1=O)NC(c1ccc(Cl)cc1)C1CC1 nan
153065968 180696 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 354 6 1 6 2.2 CC(C)Oc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
CHEMBL4762154 180696 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 354 6 1 6 2.2 CC(C)Oc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
153585680 180704 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 314 4 1 5 1.5 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(F)cc1 nan
CHEMBL4762210 180704 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 314 4 1 5 1.5 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(F)cc1 nan
151392727 181141 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 464 6 1 8 2.7 C[C@H](NC(=O)Cn1nc2ccc(N3CCCCC3)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4777046 181141 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 464 6 1 8 2.7 C[C@H](NC(=O)Cn1nc2ccc(N3CCCCC3)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
134043805 181187 1 None 3 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 6 1 6 2.0 CC(NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4777673 181187 1 None 3 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 6 1 6 2.0 CC(NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)cc1 nan
153585533 181469 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 372 5 1 5 3.0 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(-c2ccccc2)cc1 nan
CHEMBL4781160 181469 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 372 5 1 5 3.0 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(-c2ccccc2)cc1 nan
153585698 181839 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 331 4 1 6 1.4 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4785855 181839 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 331 4 1 6 1.4 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)cc1 nan
149374815 181919 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3cnccn3c2=O)cc1 nan
CHEMBL4786952 181919 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3cnccn3c2=O)cc1 nan
153585657 181988 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 360 4 1 5 2.1 O=C(Cn1nc2ccc(F)cn2c1=O)NC1(c2ccc(Cl)cc2)CC1 nan
CHEMBL4787820 181988 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 360 4 1 5 2.1 O=C(Cn1nc2ccc(F)cn2c1=O)NC1(c2ccc(Cl)cc2)CC1 nan
121349628 181443 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 10.1021/acs.jmedchem.1c00820
121349628 181443 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 nan
CHEMBL4780801 181443 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 10.1021/acs.jmedchem.1c00820
CHEMBL4780801 181443 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 nan
121349739 181588 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 6 1 6 2.4 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4782619 181588 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 6 1 6 2.4 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)F)cc1 nan
121349631 181900 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
CHEMBL4786722 181900 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
122195502 123598 0 None - 1 Human 5.0 pEC50 = 5 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 402 8 2 3 3.9 COc1cccc(C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633717 123598 0 None - 1 Human 5.0 pEC50 = 5 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 402 8 2 3 3.9 COc1cccc(C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
121349564 181182 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349564 181182 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
CHEMBL4777630 181182 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4777630 181182 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
121349633 182135 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
CHEMBL4789631 182135 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
164628435 185708 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1cccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4874254 185708 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1cccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c1 10.1021/acs.jmedchem.1c00820
26532940 123601 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 C[C@H](NC(=O)CNC(=O)c1ccc(Cl)cc1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633721 123601 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 C[C@H](NC(=O)CNC(=O)c1ccc(Cl)cc1)c1ccccc1 10.1021/acsmedchemlett.5b00247
164621186 185512 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 323 4 0 6 2.4 Cc1ccc([C@H](C)OC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4871591 185512 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 323 4 0 6 2.4 Cc1ccc([C@H](C)OC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349572 181264 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
CHEMBL4778561 181264 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
121349566 182070 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
CHEMBL4788831 182070 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
121349806 182792 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4797857 182792 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(C(F)(F)F)cc1 nan
2114212 20730 14 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 308 5 1 5 1.2 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccccc1 10.1021/acs.jmedchem.1c00820
CHEMBL1310918 20730 14 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 308 5 1 5 1.2 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccccc1 10.1021/acs.jmedchem.1c00820
121349764 182306 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 360 4 1 5 2.5 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(F)cc1Cl nan
CHEMBL4792090 182306 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 360 4 1 5 2.5 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(F)cc1Cl nan
36428174 181360 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4779855 181360 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.1c00820
121349734 181514 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 nan
CHEMBL4781729 181514 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 nan
121349683 182141 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c12 nan
CHEMBL4789720 182141 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c12 nan
121349710 182366 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
CHEMBL4792828 182366 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
121349767 182748 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4797410 182748 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
2303171 123600 1 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 C[C@H](NC(=O)CNC(=O)c1ccccc1Cl)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633719 123600 1 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 C[C@H](NC(=O)CNC(=O)c1ccccc1Cl)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349643 182864 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 404 4 1 5 2.6 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(F)cc1Br nan
CHEMBL4798899 182864 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 404 4 1 5 2.6 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(F)cc1Br nan
164611430 184641 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cn1 10.1021/acs.jmedchem.1c00820
CHEMBL4857947 184641 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cn1 10.1021/acs.jmedchem.1c00820
121349781 181266 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
CHEMBL4778563 181266 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
121349675 181383 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 4 1 5 3.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
CHEMBL4780038 181383 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 4 1 5 3.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
121349763 181886 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 366 5 1 6 2.5 COc1cc(C)ccc1[C@H](C)NC(=O)[C@@H](C)n1nnc2ccccc2c1=O nan
CHEMBL4786501 181886 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 366 5 1 6 2.5 COc1cc(C)ccc1[C@H](C)NC(=O)[C@@H](C)n1nnc2ccccc2c1=O nan
121349809 182579 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
CHEMBL4795372 182579 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
121349689 182637 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
CHEMBL4796061 182637 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
2548547 2118 39 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 O=C(N[C@H](c1ccccc1)C)CNC(=O)c1cccc(c1)Cl 10.1021/acsmedchemlett.5b00247
8766 2118 39 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 O=C(N[C@H](c1ccccc1)C)CNC(=O)c1cccc(c1)Cl 10.1021/acsmedchemlett.5b00247
CHEMBL3633720 2118 39 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 O=C(N[C@H](c1ccccc1)C)CNC(=O)c1cccc(c1)Cl 10.1021/acsmedchemlett.5b00247
1555702 123599 2 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 282 5 2 2 2.3 C[C@H](NC(=O)CNC(=O)c1ccccc1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633718 123599 2 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 282 5 2 2 2.3 C[C@H](NC(=O)CNC(=O)c1ccccc1)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349597 181229 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(Cl)ccc3c2=O)cc1 nan
CHEMBL4778124 181229 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(Cl)ccc3c2=O)cc1 nan
121349786 181671 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 nan
CHEMBL4783626 181671 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 nan
28918448 123620 2 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 312 6 2 3 2.3 COc1cccc(C(=O)NCC(=O)N[C@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633895 123620 2 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 312 6 2 3 2.3 COc1cccc(C(=O)NCC(=O)N[C@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
121349574 182237 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 10.1021/acs.jmedchem.1c00820
121349574 182237 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4790968 182237 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4790968 182237 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 nan
121349782 182462 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c2c1 nan
CHEMBL4794046 182462 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c2c1 nan
121349740 181509 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
CHEMBL4781651 181509 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
121349745 181630 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 10.1021/acs.jmedchem.1c00820
121349745 181630 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 nan
CHEMBL4783071 181630 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 10.1021/acs.jmedchem.1c00820
CHEMBL4783071 181630 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 nan
121349593 182291 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
CHEMBL4791792 182291 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
40719079 123612 1 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633885 123612 1 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349656 182907 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 424 5 1 6 2.8 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3F)c(=O)c12 nan
CHEMBL4799483 182907 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 424 5 1 6 2.8 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3F)c(=O)c12 nan
121349786 181671 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4783626 181671 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349593 182291 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F nan
CHEMBL4791792 182291 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F nan
2695546 185534 12 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4871792 185534 12 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
2548543 123621 2 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 C[C@@H](NC(=O)CNC(=O)c1cccc(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633896 123621 2 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 C[C@@H](NC(=O)CNC(=O)c1cccc(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
11685 4075 17 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 10.1021/acs.jmedchem.1c00820
11685 4075 17 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 nan
121349608 4075 17 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 10.1021/acs.jmedchem.1c00820
121349608 4075 17 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 nan
CHEMBL4779773 4075 17 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 10.1021/acs.jmedchem.1c00820
CHEMBL4779773 4075 17 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 nan
2714485 182360 2 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 326 4 1 5 1.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(F)cc1 nan
CHEMBL4792727 182360 2 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 326 4 1 5 1.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(F)cc1 nan
121349719 182677 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349719 182677 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 nan
CHEMBL4796493 182677 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4796493 182677 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 nan
8036946 182857 2 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4798779 182857 2 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
121349614 181083 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)c(C)c1 nan
CHEMBL4776329 181083 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)c(C)c1 nan
27783537 181101 1 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 386 4 1 5 2.4 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Br)cc1 nan
CHEMBL4776509 181101 1 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 386 4 1 5 2.4 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Br)cc1 nan
121349728 181234 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349728 181234 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 nan
CHEMBL4778172 181234 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4778172 181234 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 nan
41757362 181631 1 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
CHEMBL4783081 181631 1 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
121349658 182121 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4789475 182121 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 10.1021/acs.jmedchem.1c00820
27785340 182889 1 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
CHEMBL4799237 182889 1 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
27754276 185349 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 5 1 5 2.4 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4869182 185349 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 5 1 5 2.4 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C)cc1 10.1021/acs.jmedchem.1c00820
7534868 123605 2 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 296 5 2 2 2.6 Cc1cccc(C(=O)NCC(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633878 123605 2 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 296 5 2 2 2.6 Cc1cccc(C(=O)NCC(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
122195644 123615 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 334 5 2 2 3.1 C[C@H](NC(=O)CNC(=O)c1cc(F)cc(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633888 123615 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 334 5 2 2 3.1 C[C@H](NC(=O)CNC(=O)c1cc(F)cc(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349701 181362 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc12 nan
CHEMBL4779884 181362 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc12 nan
121349805 182538 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(OC)c3c2=O)cc1 nan
CHEMBL4794908 182538 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(OC)c3c2=O)cc1 nan
121349755 181221 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
CHEMBL4778062 181221 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
121349734 181514 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4781729 181514 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 10.1021/acs.jmedchem.1c00820
27785340 182889 1 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
CHEMBL4799237 182889 1 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
122195501 123597 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 342 7 3 4 1.7 COc1cccc(C(=O)N[C@@H](CO)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633716 123597 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 342 7 3 4 1.7 COc1cccc(C(=O)N[C@@H](CO)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
8036887 184157 1 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 5 1 5 1.7 C[C@@H](CNC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
CHEMBL4850747 184157 1 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 5 1 5 1.7 C[C@@H](CNC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
121349639 181835 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
121349639 181835 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
CHEMBL4785741 181835 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
CHEMBL4785741 181835 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
3341369 47381 7 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 328 4 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCc1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL1546963 47381 7 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 328 4 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCc1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
121349694 181633 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 10.1021/acs.jmedchem.1c00820
121349694 181633 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 nan
CHEMBL4783106 181633 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 10.1021/acs.jmedchem.1c00820
CHEMBL4783106 181633 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 nan
121349596 182859 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4798863 182859 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
164609046 183903 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.5 Cc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4847108 183903 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.5 Cc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349780 185787 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 5 1 5 1.5 Cc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4875522 185787 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 5 1 5 1.5 Cc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349738 181515 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 5 1 5 3.1 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4781754 181515 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 5 1 5 3.1 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
121349572 181264 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4778561 181264 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
2109722 123617 2 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 342 7 2 4 2.3 COc1cc(OC)cc(C(=O)NCC(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633890 123617 2 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 342 7 2 4 2.3 COc1cc(OC)cc(C(=O)NCC(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
121349658 182121 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 nan
CHEMBL4789475 182121 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 nan
121349548 182847 1 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 338 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4798667 182847 1 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 338 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
8036946 182857 2 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4798779 182857 2 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 nan
26810968 185701 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 358 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1cccc2ccccc12 10.1021/acs.jmedchem.1c00820
CHEMBL4874147 185701 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 358 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1cccc2ccccc12 10.1021/acs.jmedchem.1c00820
28918445 123608 1 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 312 6 2 3 2.3 COc1cccc(C(=O)NCC(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633881 123608 1 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 312 6 2 3 2.3 COc1cccc(C(=O)NCC(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
121349633 182135 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
CHEMBL4789631 182135 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
121349767 182748 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 nan
CHEMBL4797410 182748 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 nan
121349559 181254 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc2c1 nan
CHEMBL4778354 181254 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc2c1 nan
121349615 182543 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 366 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
CHEMBL4795005 182543 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 366 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
121349746 182802 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4797979 182802 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349645 181136 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4776988 181136 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
121349720 181661 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(OC)cccc3c2=O)cc1 nan
CHEMBL4783544 181661 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(OC)cccc3c2=O)cc1 nan
122195642 123613 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633886 123613 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349688 182316 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
CHEMBL4792174 182316 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
121349659 181683 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
CHEMBL4783774 181683 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
121349600 182003 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c2c1 nan
CHEMBL4788013 182003 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c2c1 nan
3376937 123618 45 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 365 4 3 4 3.3 COc1cc(OC)cc(C(=O)NNC(=O)Nc2cccc3ccccc23)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633893 123618 45 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 365 4 3 4 3.3 COc1cc(OC)cc(C(=O)NNC(=O)Nc2cccc3ccccc23)c1 10.1021/acsmedchemlett.5b00247
122195500 123596 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 326 6 2 3 2.7 COc1cccc(C(=O)N[C@H](C)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633715 123596 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 326 6 2 3 2.7 COc1cccc(C(=O)N[C@H](C)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
121349746 182802 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
CHEMBL4797979 182802 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
2496250 28739 7 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 338 6 1 6 1.2 COc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL1380104 28739 7 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 338 6 1 6 1.2 COc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
122195640 123610 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 366 6 2 3 3.2 C[C@H](NC(=O)CNC(=O)c1cccc(OC(F)(F)F)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633883 123610 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 366 6 2 3 3.2 C[C@H](NC(=O)CNC(=O)c1cccc(OC(F)(F)F)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
122195643 123614 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1cc(Cl)cc(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633887 123614 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1cc(Cl)cc(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349558 181390 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 428 5 1 6 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
CHEMBL4780121 181390 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 428 5 1 6 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
121349685 181551 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 nan
CHEMBL4782204 181551 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 nan
121349623 181518 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc12 nan
CHEMBL4781805 181518 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc12 nan
121349588 181654 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 6 1 6 3.0 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4783365 181654 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 6 1 6 3.0 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
121349773 181846 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc2c1 nan
CHEMBL4785980 181846 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc2c1 nan
121349793 181241 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 366 5 1 6 2.5 COc1cc(C)ccc1[C@H](C)NC(=O)[C@H](C)n1nnc2ccccc2c1=O nan
CHEMBL4778263 181241 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 366 5 1 6 2.5 COc1cc(C)ccc1[C@H](C)NC(=O)[C@H](C)n1nnc2ccccc2c1=O nan
122195639 123609 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.3 C[C@H](NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633882 123609 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.3 C[C@H](NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
122195641 123611 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1cccc(Cl)c1Cl)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633884 123611 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1cccc(Cl)c1Cl)c1ccccc1 10.1021/acsmedchemlett.5b00247
2714528 181896 2 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 308 4 1 5 1.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 nan
CHEMBL4786641 181896 2 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 308 4 1 5 1.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 nan
2714527 184823 2 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 308 4 1 5 1.7 C[C@@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
CHEMBL4861019 184823 2 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 308 4 1 5 1.7 C[C@@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
121349679 185686 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 6 1 6 1.5 COc1ccc(C[C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4873905 185686 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 6 1 6 1.5 COc1ccc(C[C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
28821961 123607 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 300 5 2 2 2.4 C[C@H](NC(=O)CNC(=O)c1cccc(F)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633880 123607 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 300 5 2 2 2.4 C[C@H](NC(=O)CNC(=O)c1cccc(F)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349685 181551 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4782204 181551 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 10.1021/acs.jmedchem.1c00820
122195638 123606 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 307 5 2 3 2.2 C[C@H](NC(=O)CNC(=O)c1cccc(C#N)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633879 123606 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 307 5 2 3 2.2 C[C@H](NC(=O)CNC(=O)c1cccc(C#N)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349795 182867 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
CHEMBL4798933 182867 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
27838947 184849 2 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1cccc(Cl)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4861445 184849 2 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1cccc(Cl)c1 10.1021/acs.jmedchem.1c00820
2998350 37870 6 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 334 3 1 5 2.0 O=C(Cn1nnc2ccccc2c1=O)NC1CCCc2ccccc21 10.1021/acs.jmedchem.1c00820
CHEMBL1460960 37870 6 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 334 3 1 5 2.0 O=C(Cn1nnc2ccccc2c1=O)NC1CCCc2ccccc21 10.1021/acs.jmedchem.1c00820
122195499 123595 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 326 6 2 3 2.7 COc1cccc(C(=O)N[C@@H](C)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633714 123595 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 326 6 2 3 2.7 COc1cccc(C(=O)N[C@@H](C)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
41757362 181631 1 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4783081 181631 1 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349753 182312 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 nan
CHEMBL4792136 182312 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 nan
2856847 123619 10 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 299 5 1 3 3.4 CC(NC(=O)CSC(=O)c1ccccc1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633894 123619 10 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 299 5 1 3 3.4 CC(NC(=O)CSC(=O)c1ccccc1)c1ccccc1 10.1021/acsmedchemlett.5b00247
164619649 185184 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccccc1Cl 10.1021/acs.jmedchem.1c00820
CHEMBL4866435 185184 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccccc1Cl 10.1021/acs.jmedchem.1c00820
121349671 181171 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 350 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
CHEMBL4777495 181171 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 350 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
121349778 181774 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 3.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
CHEMBL4784744 181774 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 3.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
121349756 181985 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
CHEMBL4787761 181985 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
121349555 182055 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
CHEMBL4788631 182055 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
121349787 182090 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
CHEMBL4789079 182090 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
121349554 182957 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(OC)ccc3c2=O)cc1 nan
CHEMBL4800089 182957 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(OC)ccc3c2=O)cc1 nan
164617704 183949 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 374 6 1 7 1.4 COc1ccc([C@H](C)NS(=O)(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4847795 183949 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 374 6 1 7 1.4 COc1ccc([C@H](C)NS(=O)(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
164617980 184446 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)nc1 10.1021/acs.jmedchem.1c00820
CHEMBL4855076 184446 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)nc1 10.1021/acs.jmedchem.1c00820
122195645 123616 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 394 5 2 2 3.7 C[C@H](NC(=O)CNC(=O)c1cc(Cl)cc(Br)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633889 123616 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 394 5 2 2 3.7 C[C@H](NC(=O)CNC(=O)c1cc(Cl)cc(Br)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
78596259 184793 1 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 4 1 5 2.3 CC(NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4860510 184793 1 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 4 1 5 2.3 CC(NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
121349587 181830 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
CHEMBL4785669 181830 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
164620660 185363 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 384 6 1 5 2.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccc(-c2ccccc2)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4869485 185363 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 384 6 1 5 2.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccc(-c2ccccc2)cc1 10.1021/acs.jmedchem.1c00820
27783537 181101 1 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 386 4 1 5 2.4 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Br)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4776509 181101 1 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 386 4 1 5 2.4 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Br)cc1 10.1021/acs.jmedchem.1c00820
121349569 181333 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
CHEMBL4779481 181333 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
121349561 182148 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
CHEMBL4789791 182148 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
121349769 182345 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
CHEMBL4792561 182345 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
121349596 182859 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
CHEMBL4798863 182859 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
164620725 185503 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.2 COc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4871506 185503 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.2 COc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
36428174 181360 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4779855 181360 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
121349753 182312 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4792136 182312 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 10.1021/acs.jmedchem.1c00820
11685 4075 17 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist-induced <i>in vitro</i> calcium mobilization assay, using CHO-T-REx cells stably expressing hGPR139Agonist-induced <i>in vitro</i> calcium mobilization assay, using CHO-T-REx cells stably expressing hGPR139
Guide to Pharmacology 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 34260228
121349608 4075 17 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist-induced <i>in vitro</i> calcium mobilization assay, using CHO-T-REx cells stably expressing hGPR139Agonist-induced <i>in vitro</i> calcium mobilization assay, using CHO-T-REx cells stably expressing hGPR139
Guide to Pharmacology 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 34260228
CHEMBL4779773 4075 17 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist-induced <i>in vitro</i> calcium mobilization assay, using CHO-T-REx cells stably expressing hGPR139Agonist-induced <i>in vitro</i> calcium mobilization assay, using CHO-T-REx cells stably expressing hGPR139
Guide to Pharmacology 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 34260228
2144 2324 0 None - 1 Human 3.5 pEC50 = 3.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 24826842
3313 2324 0 None - 1 Human 3.5 pEC50 = 3.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 24826842
6140 2324 0 None - 1 Human 3.5 pEC50 = 3.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 24826842
6925665 2324 0 None - 1 Human 3.5 pEC50 = 3.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 24826842
CHEMBL301523 2324 0 None - 1 Human 3.5 pEC50 = 3.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 24826842
DB00120 2324 0 None - 1 Human 3.5 pEC50 = 3.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 24826842
2780 2341 101 None 13 2 Human 3.7 pEC50 = 3.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 24826842
6305 2341 101 None 13 2 Human 3.7 pEC50 = 3.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 24826842
6923516 2341 101 None 13 2 Human 3.7 pEC50 = 3.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 24826842
717 2341 101 None 13 2 Human 3.7 pEC50 = 3.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 24826842
CHEMBL54976 2341 101 None 13 2 Human 3.7 pEC50 = 3.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 24826842
DB00150 2341 101 None 13 2 Human 3.7 pEC50 = 3.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 24826842
7799 996 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 365 4 3 4 3.3 COc1cc(OC)cc(c1)C(=O)NNC(=O)Nc1ccc2c(c1)cccc2 24900311
86277840 996 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 365 4 3 4 3.3 COc1cc(OC)cc(c1)C(=O)NNC(=O)Nc1ccc2c(c1)cccc2 24900311
2144 2324 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 None
3313 2324 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 None
6140 2324 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 None
6925665 2324 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 None
CHEMBL301523 2324 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 None
DB00120 2324 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 None
2780 2341 101 None 13 2 Human 8.3 pIC50 = 8.3 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N None
6305 2341 101 None 13 2 Human 8.3 pIC50 = 8.3 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N None
6923516 2341 101 None 13 2 Human 8.3 pIC50 = 8.3 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N None
717 2341 101 None 13 2 Human 8.3 pIC50 = 8.3 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N None
CHEMBL54976 2341 101 None 13 2 Human 8.3 pIC50 = 8.3 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N None
DB00150 2341 101 None 13 2 Human 8.3 pIC50 = 8.3 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N None
12363 2710 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Inhibition of Ca<sup>2+</sup> mobilizationInhibition of Ca<sup>2+</sup> mobilization
Guide to Pharmacology 340 1 1 3 4.8 Oc1cc2c(cc1)c(=O)c(c1ccc(Cl)cc1)c(o2)C(F)(F)F 36736525
5348723 2710 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Inhibition of Ca<sup>2+</sup> mobilizationInhibition of Ca<sup>2+</sup> mobilization
Guide to Pharmacology 340 1 1 3 4.8 Oc1cc2c(cc1)c(=O)c(c1ccc(Cl)cc1)c(o2)C(F)(F)F 36736525
2144 2324 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
3313 2324 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
6140 2324 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
6925665 2324 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
CHEMBL301523 2324 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
DB00120 2324 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
2780 2341 101 None 13 2 Human 4.6 pIC50 = 4.6 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
6305 2341 101 None 13 2 Human 4.6 pIC50 = 4.6 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
6923516 2341 101 None 13 2 Human 4.6 pIC50 = 4.6 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
717 2341 101 None 13 2 Human 4.6 pIC50 = 4.6 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
CHEMBL54976 2341 101 None 13 2 Human 4.6 pIC50 = 4.6 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
DB00150 2341 101 None 13 2 Human 4.6 pIC50 = 4.6 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
789353 2322 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 329 4 1 2 4.8 Cc1ccccc1NS(=O)(=O)c1ccc(cc1)C1CCCCC1 19525486
8774 2322 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 329 4 1 2 4.8 Cc1ccccc1NS(=O)(=O)c1ccc(cc1)C1CCCCC1 19525486
5017692 2709 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 289 3 0 2 3.4 COc1ccc(cc1)C1N(c2ccccc2)C(=O)C1(F)F 26027661
8775 2709 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 289 3 0 2 3.4 COc1ccc(cc1)C1N(c2ccccc2)C(=O)C1(F)F 26027661




Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Affinity)
# tested GPCRs
(Affinity)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
153585580 178864 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 411 6 1 8 1.7 COc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
CHEMBL4740491 178864 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 411 6 1 8 1.7 COc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
148397968 179055 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
CHEMBL4742901 179055 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
153585666 179057 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 378 5 1 6 2.2 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
CHEMBL4742949 179057 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 378 5 1 6 2.2 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
147451915 179107 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 348 4 1 5 2.2 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4743612 179107 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 348 4 1 5 2.2 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585625 179113 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 324 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(C)ccn3c2=O)cc1 nan
CHEMBL4743662 179113 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 324 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(C)ccn3c2=O)cc1 nan
153585420 179230 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 364 4 1 5 2.7 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4744927 179230 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 364 4 1 5 2.7 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
153585722 179367 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 394 5 1 6 2.6 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
CHEMBL4746401 179367 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 394 5 1 6 2.6 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
162649907 179503 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 378 5 2 7 1.6 CNc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
CHEMBL4748076 179503 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 378 5 2 7 1.6 CNc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
152844759 179519 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ncc(C3CC3)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4748306 179519 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ncc(C3CC3)cn2c1=O)c1ccc(Cl)c(F)c1 nan
153585686 179673 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 410 6 1 7 2.3 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 nan
CHEMBL4750288 179673 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 410 6 1 7 2.3 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 nan
147641221 179716 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1 nan
CHEMBL4750914 179716 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1 nan
153585718 179761 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2cc(C#N)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4751304 179761 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2cc(C#N)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585581 179781 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2ccc(C#N)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4751501 179781 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2ccc(C#N)cn2c1=O)c1ccc(Cl)c(F)c1 nan
153585708 179875 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 348 4 1 5 2.2 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4752808 179875 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 348 4 1 5 2.2 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(Cl)cc1 nan
153585648 179935 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 366 4 1 5 2.3 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4753388 179935 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 366 4 1 5 2.3 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(Cl)c(F)c1 nan
162653764 179951 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2cc(C3CC3)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4753640 179951 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2cc(C3CC3)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585540 180026 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 398 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4754565 180026 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 398 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585467 180027 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 410 6 1 7 2.3 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2c1 nan
CHEMBL4754576 180027 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 410 6 1 7 2.3 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2c1 nan
152015494 180041 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2c(C3CC3)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4754735 180041 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2c(C3CC3)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
150352344 180189 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ccc(C3CC3)nn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756243 180189 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ccc(C3CC3)nn2c1=O)c1ccc(Cl)c(F)c1 nan
162655689 180201 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 379 5 1 7 1.6 COc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
CHEMBL4756356 180201 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 379 5 1 7 1.6 COc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
153585712 180209 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 419 6 2 7 2.0 C[C@H](NC(=O)Cn1nc2cc(NC3COC3)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756431 180209 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 419 6 2 7 2.0 C[C@H](NC(=O)Cn1nc2cc(NC3COC3)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585415 180306 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ncccn2c1=O nan
CHEMBL4757506 180306 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ncccn2c1=O nan
153585630 180413 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 346 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(F)cn3c2=O)cc1F nan
CHEMBL4758841 180413 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 346 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(F)cn3c2=O)cc1F nan
153585534 180502 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 413 5 1 7 2.1 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)c(F)c3)c(=O)n2c1 nan
CHEMBL4759991 180502 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 413 5 1 7 2.1 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)c(F)c3)c(=O)n2c1 nan
153585651 180620 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 382 4 1 5 2.8 C[C@H](NC(=O)Cn1nc2cc(Cl)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4761154 180620 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 382 4 1 5 2.8 C[C@H](NC(=O)Cn1nc2cc(Cl)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585591 180694 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1cc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)ccc1Cl nan
CHEMBL4762126 180694 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1cc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)ccc1Cl nan
162659465 180738 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 379 5 1 7 1.6 COc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
CHEMBL4762651 180738 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 379 5 1 7 1.6 COc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
153585610 180863 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ccccn2c1=O nan
CHEMBL4764290 180863 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ccccn2c1=O nan
153585689 180924 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 340 5 1 6 1.7 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc2c1 nan
CHEMBL4764967 180924 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 340 5 1 6 1.7 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc2c1 nan
162661302 180935 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 383 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4765018 180935 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 383 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585427 181399 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 324 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(C)cn3c2=O)cc1 nan
CHEMBL4780358 181399 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 324 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(C)cn3c2=O)cc1 nan
153585638 181618 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 379 5 1 7 1.6 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
CHEMBL4782901 181618 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 379 5 1 7 1.6 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
153585409 181889 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 394 5 1 6 2.6 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2c1 nan
CHEMBL4786542 181889 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 394 5 1 6 2.6 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2c1 nan
147410414 182099 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n12 nan
CHEMBL4789252 182099 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n12 nan
153585385 182235 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 360 5 1 6 2.0 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n12 nan
CHEMBL4790949 182235 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 360 5 1 6 2.0 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n12 nan
162671538 182247 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 417 4 1 6 2.6 C[C@H](NC(=O)Cn1nc2c(C(F)(F)F)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4791193 182247 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 417 4 1 6 2.6 C[C@H](NC(=O)Cn1nc2c(C(F)(F)F)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
162671011 182362 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 345 4 1 6 1.7 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n2n1 nan
CHEMBL4792732 182362 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 345 4 1 6 1.7 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n2n1 nan
148156995 182373 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 460 8 2 8 2.3 C[C@H](NC(=O)Cn1nc2c(NCC(F)F)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4792896 182373 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 460 8 2 8 2.3 C[C@H](NC(=O)Cn1nc2c(NCC(F)F)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
151533016 182388 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 339 5 2 6 1.7 CNc1cccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc12 nan
CHEMBL4793093 182388 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 339 5 2 6 1.7 CNc1cccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc12 nan
153585429 182830 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 340 5 1 6 1.7 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)n12 nan
CHEMBL4798385 182830 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 340 5 1 6 1.7 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)n12 nan
153585699 182919 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 362 4 1 5 2.5 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
CHEMBL4799647 182919 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 362 4 1 5 2.5 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
153585528 182982 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1Cl nan
CHEMBL4800338 182982 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1Cl nan
162644596 178839 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
CHEMBL4740228 178839 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
153585418 178867 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 434 5 1 8 1.4 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4740519 178867 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 434 5 1 8 1.4 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585684 178953 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 377 4 1 6 2.2 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
CHEMBL4741467 178953 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 377 4 1 6 2.2 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
152956498 179130 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 324 4 1 5 2.2 Cc1ccc([C@H](C)NC(=O)C(C)n2nc3ccccn3c2=O)cc1 nan
CHEMBL4743938 179130 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 324 4 1 5 2.2 Cc1ccc([C@H](C)NC(=O)C(C)n2nc3ccccn3c2=O)cc1 nan
153585688 179178 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4744340 179178 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162648790 179207 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
CHEMBL4744737 179207 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
153585420 179230 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 364 4 1 5 2.7 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4744927 179230 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 364 4 1 5 2.7 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
162647825 179255 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
CHEMBL4745096 179255 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
152005060 179282 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 447 5 1 8 1.3 C[C@H](NC(=O)Cn1nc2c(N3CCN(C)CC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4745432 179282 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 447 5 1 8 1.3 C[C@H](NC(=O)Cn1nc2c(N3CCN(C)CC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
150995037 179339 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cnccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4746108 179339 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cnccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585512 179448 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 367 4 1 6 1.7 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4747431 179448 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 367 4 1 6 1.7 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(Cl)c(F)c1 nan
162650006 179545 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2cccnn2c1=O nan
CHEMBL4748681 179545 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2cccnn2c1=O nan
151976938 179660 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
CHEMBL4750143 179660 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
153585686 179673 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 410 6 1 7 2.3 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 nan
CHEMBL4750288 179673 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 410 6 1 7 2.3 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 nan
147634500 179698 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ncc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1F nan
CHEMBL4750692 179698 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ncc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1F nan
147641221 179716 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1 nan
CHEMBL4750914 179716 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1 nan
153585718 179761 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2cc(C#N)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4751304 179761 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2cc(C#N)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585721 179770 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 383 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2ncc(Cl)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4751414 179770 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 383 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2ncc(Cl)cn2c1=O)c1ccc(Cl)c(F)c1 nan
153585581 179781 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2ccc(C#N)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4751501 179781 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2ccc(C#N)cn2c1=O)c1ccc(Cl)c(F)c1 nan
153585514 179792 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1 nan
CHEMBL4751629 179792 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1 nan
153585541 179800 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 341 5 1 7 1.1 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc2n1 nan
CHEMBL4751720 179800 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 341 5 1 7 1.1 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc2n1 nan
162653366 179878 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 410 6 2 8 1.7 CNc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc12 nan
CHEMBL4752829 179878 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 410 6 2 8 1.7 CNc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc12 nan
153585655 179894 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 493 7 1 8 2.9 COC1CCN(c2ccn3c(=O)n(CC(=O)N[C@@H](C)c4ccc(OC(F)(F)F)cc4)nc3c2)CC1 nan
CHEMBL4752993 179894 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 493 7 1 8 2.9 COC1CCN(c2ccn3c(=O)n(CC(=O)N[C@@H](C)c4ccc(OC(F)(F)F)cc4)nc3c2)CC1 nan
153585421 179939 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 447 5 1 7 2.4 CC1COCCN1c1cccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n12 nan
CHEMBL4753419 179939 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 447 5 1 7 2.4 CC1COCCN1c1cccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n12 nan
147378727 179945 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 6 1 6 2.1 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)c(F)c1 nan
CHEMBL4753547 179945 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 6 1 6 2.1 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)c(F)c1 nan
162653797 179948 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1F nan
CHEMBL4753587 179948 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1F nan
148512747 179975 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1nccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc12 nan
CHEMBL4753915 179975 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1nccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc12 nan
149101043 180021 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4754476 180021 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585478 180023 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4754503 180023 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585540 180026 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 398 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4754565 180026 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 398 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585445 180175 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 382 4 1 5 2.5 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4756137 180175 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 382 4 1 5 2.5 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(C(F)(F)F)cc1 nan
94095050 180229 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 5 1 6 2.3 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4756787 180229 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 5 1 6 2.3 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162657043 180240 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 379 5 1 7 1.6 COc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2n1 nan
CHEMBL4756879 180240 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 379 5 1 7 1.6 COc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2n1 nan
162656575 180301 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)c(F)c1 nan
CHEMBL4757480 180301 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)c(F)c1 nan
162656504 180314 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4757619 180314 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
152460205 180352 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 451 6 2 8 1.5 C[C@H](NC(=O)Cn1nc2cccc(N3CC(O)C3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4758096 180352 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 451 6 2 8 1.5 C[C@H](NC(=O)Cn1nc2cccc(N3CC(O)C3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585448 180368 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 411 6 1 8 1.7 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2n1 nan
CHEMBL4758322 180368 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 411 6 1 8 1.7 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2n1 nan
149421402 180374 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 452 7 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(OC3COC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4758375 180374 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 452 7 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(OC3COC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162657688 180473 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)ccc1Cl nan
CHEMBL4759611 180473 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)ccc1Cl nan
162657416 180538 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
CHEMBL4760528 180538 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
150924716 180584 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 340 5 1 6 1.7 COc1cccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc12 nan
CHEMBL4760914 180584 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 340 5 1 6 1.7 COc1cccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc12 nan
153585574 180639 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 C[C@H](NC(=O)[C@@H](C)n1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4761321 180639 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 C[C@H](NC(=O)[C@@H](C)n1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
162660420 180693 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 5 1 6 2.0 CC[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4762121 180693 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 5 1 6 2.0 CC[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585591 180694 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1cc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)ccc1Cl nan
CHEMBL4762126 180694 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1cc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)ccc1Cl nan
147987797 180702 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4762206 180702 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(C(F)(F)F)cc1 nan
147323186 180802 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 1 6 1.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3cnc(C)cn3c2=O)cc1 nan
CHEMBL4763362 180802 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 1 6 1.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3cnc(C)cn3c2=O)cc1 nan
153585610 180863 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ccccn2c1=O nan
CHEMBL4764290 180863 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ccccn2c1=O nan
162661581 180882 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 4 1 5 2.7 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ccccn2c1=O nan
CHEMBL4764506 180882 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 4 1 5 2.7 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ccccn2c1=O nan
152494840 180915 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC(O)CC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4764839 180915 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC(O)CC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162661302 180935 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 383 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4765018 180935 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 383 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585547 181159 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4777214 181159 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
162644369 181248 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 343 4 1 6 1.5 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(C)ccnn3c2=O)cc1F nan
CHEMBL4778327 181248 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 343 4 1 6 1.5 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(C)ccnn3c2=O)cc1F nan
162665057 181484 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4781404 181484 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(Cl)c1 nan
150561998 181549 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 475 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2c(I)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4782195 181549 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 475 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2c(I)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
149618414 181679 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 2 6 1.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(N)cccn3c2=O)cc1 nan
CHEMBL4783739 181679 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 2 6 1.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(N)cccn3c2=O)cc1 nan
153585463 181825 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 433 5 1 7 2.0 C[C@H](NC(=O)Cn1nc2cccc(N3CCOCC3)n2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4785639 181825 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 433 5 1 7 2.0 C[C@H](NC(=O)Cn1nc2cccc(N3CCOCC3)n2c1=O)c1ccc(Cl)c(F)c1 nan
153585417 181845 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1Cl nan
CHEMBL4785963 181845 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1Cl nan
153585609 181890 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 465 6 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4786573 181890 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 465 6 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
151394869 181954 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4787308 181954 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585701 181971 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 463 6 1 7 3.3 C[C@H](NC(=O)Cn1nc2cccc(N3CCCCC3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4787547 181971 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 463 6 1 7 3.3 C[C@H](NC(=O)Cn1nc2cccc(N3CCCCC3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
151043804 182093 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4789123 182093 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
162670176 182169 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 377 5 1 6 2.2 CC(C)[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4790080 182169 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 377 5 1 6 2.2 CC(C)[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585385 182235 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 360 5 1 6 2.0 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n12 nan
CHEMBL4790949 182235 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 360 5 1 6 2.0 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n12 nan
153585679 182341 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1F nan
CHEMBL4792515 182341 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1F nan
162671011 182362 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n2n1 nan
CHEMBL4792732 182362 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n2n1 nan
148156995 182373 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 460 8 2 8 2.3 C[C@H](NC(=O)Cn1nc2c(NCC(F)F)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4792896 182373 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 460 8 2 8 2.3 C[C@H](NC(=O)Cn1nc2c(NCC(F)F)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585524 182548 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(F)cccn3c2=O)cc1 nan
CHEMBL4795078 182548 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(F)cccn3c2=O)cc1 nan
153585504 182629 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 410 6 1 7 2.3 COc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
CHEMBL4795956 182629 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 410 6 1 7 2.3 COc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
153585386 182651 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2ccc(Cl)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4796254 182651 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2ccc(Cl)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585438 182778 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2c1 nan
CHEMBL4797724 182778 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2c1 nan
153585532 182810 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(F)n3c2=O)cc1 nan
CHEMBL4798029 182810 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(F)n3c2=O)cc1 nan
153585429 182830 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 340 5 1 6 1.7 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)n12 nan
CHEMBL4798385 182830 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 340 5 1 6 1.7 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)n12 nan
153585528 182982 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1Cl nan
CHEMBL4800338 182982 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1Cl nan
153585707 182996 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 361 5 1 7 1.4 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)nc2n1 nan
CHEMBL4800487 182996 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 361 5 1 7 1.4 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)nc2n1 nan
162644596 178839 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
CHEMBL4740228 178839 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
162648790 179207 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
CHEMBL4744737 179207 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
162647825 179255 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
CHEMBL4745096 179255 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
162649809 179465 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 458 5 1 7 2.1 C[C@H](NC(=O)Cn1nc2c(N3CCC34CN(C)C4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4747632 179465 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 458 5 1 7 2.1 C[C@H](NC(=O)Cn1nc2c(N3CCC34CN(C)C4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
151976938 179660 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
CHEMBL4750143 179660 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
147634500 179698 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ncc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1F nan
CHEMBL4750692 179698 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ncc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1F nan
149094095 179702 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 421 6 1 7 2.5 C[C@H](NC(=O)Cn1nc2ccc(C3CC3)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4750718 179702 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 421 6 1 7 2.5 C[C@H](NC(=O)Cn1nc2ccc(C3CC3)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162653366 179878 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 410 6 2 8 1.7 CNc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc12 nan
CHEMBL4752829 179878 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 410 6 2 8 1.7 CNc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc12 nan
162653797 179948 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1F nan
CHEMBL4753587 179948 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1F nan
152007746 179984 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 368 5 1 6 2.3 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3c(C)cc(C)cc3C)nc2c1 nan
CHEMBL4754043 179984 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 368 5 1 6 2.3 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3c(C)cc(C)cc3C)nc2c1 nan
153585713 180389 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(F)cn3c2=O)cc1 nan
CHEMBL4758561 180389 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(F)cn3c2=O)cc1 nan
153585574 180639 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 2.1 C[C@H](NC(=O)[C@@H](C)n1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4761321 180639 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 2.1 C[C@H](NC(=O)[C@@H](C)n1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
147987797 180702 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4762206 180702 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(C(F)(F)F)cc1 nan
162661581 180882 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 362 4 1 5 2.7 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ccccn2c1=O nan
CHEMBL4764506 180882 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 362 4 1 5 2.7 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ccccn2c1=O nan
153585547 181159 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4777214 181159 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
162644369 181248 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 343 4 1 6 1.5 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(C)ccnn3c2=O)cc1F nan
CHEMBL4778327 181248 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 343 4 1 6 1.5 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(C)ccnn3c2=O)cc1F nan
162665057 181484 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4781404 181484 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(Cl)c1 nan
151043804 182093 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4789123 182093 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585679 182341 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1F nan
CHEMBL4792515 182341 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1F nan
162670606 182356 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2n1 nan
CHEMBL4792682 182356 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2n1 nan
153585386 182651 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2ccc(Cl)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4796254 182651 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2ccc(Cl)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585532 182810 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(F)n3c2=O)cc1 nan
CHEMBL4798029 182810 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(F)n3c2=O)cc1 nan
147477854 182916 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 433 5 1 7 2.0 C[C@H](NC(=O)Cn1nc2c(N3CCOCC3)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4799618 182916 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 433 5 1 7 2.0 C[C@H](NC(=O)Cn1nc2c(N3CCOCC3)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
162644596 178839 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
CHEMBL4740228 178839 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
162648528 179234 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 337 5 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)cc1 nan
CHEMBL4744984 179234 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 337 5 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)cc1 nan
146976458 179450 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 507 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2c(I)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4747440 179450 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 507 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2c(I)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162649809 179465 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 458 5 1 7 2.1 C[C@H](NC(=O)Cn1nc2c(N3CCC34CN(C)C4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4747632 179465 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 458 5 1 7 2.1 C[C@H](NC(=O)Cn1nc2c(N3CCC34CN(C)C4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
152844759 179519 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ncc(C3CC3)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4748306 179519 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ncc(C3CC3)cn2c1=O)c1ccc(Cl)c(F)c1 nan
153585550 179812 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(C2CC2)c(F)c1 nan
CHEMBL4751886 179812 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(C2CC2)c(F)c1 nan
152007746 179984 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 368 5 1 6 2.3 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3c(C)cc(C)cc3C)nc2c1 nan
CHEMBL4754043 179984 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 368 5 1 6 2.3 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3c(C)cc(C)cc3C)nc2c1 nan
153585588 180204 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 444 5 2 7 1.7 C[C@H](NC(=O)Cn1nc2c(N3CCC34CNC4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756392 180204 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 444 5 2 7 1.7 C[C@H](NC(=O)Cn1nc2c(N3CCC34CNC4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585575 180247 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 433 5 2 8 1.0 C[C@H](NC(=O)Cn1nc2c(N3CCNCC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756937 180247 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 433 5 2 8 1.0 C[C@H](NC(=O)Cn1nc2c(N3CCNCC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585415 180306 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ncccn2c1=O nan
CHEMBL4757506 180306 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ncccn2c1=O nan
153585534 180502 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 413 5 1 7 2.1 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)c(F)c3)c(=O)n2c1 nan
CHEMBL4759991 180502 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 413 5 1 7 2.1 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)c(F)c3)c(=O)n2c1 nan
153585663 180573 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1Cl nan
CHEMBL4760812 180573 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1Cl nan
153585643 180759 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 5 1 7 1.7 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4762957 180759 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 5 1 7 1.7 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
134043805 181187 1 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 6 1 6 2.0 CC(NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4777673 181187 1 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 6 1 6 2.0 CC(NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)cc1 nan
153585542 181724 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4784153 181724 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
162667558 181880 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 331 4 1 6 1.4 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4786371 181880 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 331 4 1 6 1.4 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)cc1 nan
147410414 182099 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ccnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n12 nan
CHEMBL4789252 182099 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ccnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n12 nan
121349671 181171 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 350 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
CHEMBL4777495 181171 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 350 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
121349806 182792 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4797857 182792 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(C(F)(F)F)cc1 nan
121349656 182907 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 424 5 1 6 2.8 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3F)c(=O)c12 nan
CHEMBL4799483 182907 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 424 5 1 6 2.8 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3F)c(=O)c12 nan
121349756 181985 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
CHEMBL4787761 181985 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
27785340 182889 1 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
CHEMBL4799237 182889 1 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
27785340 182889 1 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
CHEMBL4799237 182889 1 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
121349782 182462 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c2c1 nan
CHEMBL4794046 182462 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c2c1 nan
164619649 185184 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccccc1Cl 10.1021/acs.jmedchem.1c00820
CHEMBL4866435 185184 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccccc1Cl 10.1021/acs.jmedchem.1c00820
26810968 185701 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 358 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1cccc2ccccc12 10.1021/acs.jmedchem.1c00820
CHEMBL4874147 185701 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 358 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1cccc2ccccc12 10.1021/acs.jmedchem.1c00820
11685 4075 17 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 10.1021/acs.jmedchem.1c00820
121349608 4075 17 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 10.1021/acs.jmedchem.1c00820
CHEMBL4779773 4075 17 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 10.1021/acs.jmedchem.1c00820
11685 4075 17 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 nan
121349608 4075 17 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 nan
CHEMBL4779773 4075 17 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 nan
121349786 181671 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4783626 181671 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349639 181835 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
CHEMBL4785741 181835 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
121349786 181671 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 nan
CHEMBL4783626 181671 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 nan
121349639 181835 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
CHEMBL4785741 181835 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
2695546 185534 12 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4871792 185534 12 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
121349600 182003 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c2c1 nan
CHEMBL4788013 182003 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c2c1 nan
121349548 182847 1 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 338 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4798667 182847 1 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 338 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349548 182847 1 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 338 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
CHEMBL4798667 182847 1 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 338 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
121349554 182957 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(OC)ccc3c2=O)cc1 nan
CHEMBL4800089 182957 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(OC)ccc3c2=O)cc1 nan
36428174 181360 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4779855 181360 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.1c00820
36428174 181360 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4779855 181360 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
121349659 181683 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
CHEMBL4783774 181683 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
121349593 182291 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
CHEMBL4791792 182291 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
121349593 182291 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F nan
CHEMBL4791792 182291 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F nan
121349633 182135 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
CHEMBL4789631 182135 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
121349633 182135 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
CHEMBL4789631 182135 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
2714527 184823 2 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 308 4 1 5 1.7 C[C@@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
CHEMBL4861019 184823 2 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 308 4 1 5 1.7 C[C@@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
2714528 181896 2 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 308 4 1 5 1.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 nan
CHEMBL4786641 181896 2 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 308 4 1 5 1.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 nan
27838947 184849 2 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1cccc(Cl)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4861445 184849 2 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1cccc(Cl)c1 10.1021/acs.jmedchem.1c00820
121349658 182121 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4789475 182121 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 10.1021/acs.jmedchem.1c00820
121349658 182121 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 nan
CHEMBL4789475 182121 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 nan
121349597 181229 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(Cl)ccc3c2=O)cc1 nan
CHEMBL4778124 181229 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(Cl)ccc3c2=O)cc1 nan
121349631 181900 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4786722 181900 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349631 181900 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
CHEMBL4786722 181900 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
121349615 182543 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 366 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
CHEMBL4795005 182543 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 366 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
121349564 181182 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4777630 181182 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349564 181182 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
CHEMBL4777630 181182 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
121349588 181654 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 6 1 6 3.0 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4783365 181654 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 6 1 6 3.0 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
121349572 181264 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4778561 181264 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349572 181264 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
CHEMBL4778561 181264 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
121349778 181774 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 3.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
CHEMBL4784744 181774 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 3.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
164617980 184446 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)nc1 10.1021/acs.jmedchem.1c00820
CHEMBL4855076 184446 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)nc1 10.1021/acs.jmedchem.1c00820
121349738 181515 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 5 1 5 3.1 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4781754 181515 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 5 1 5 3.1 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
121349559 181254 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc2c1 nan
CHEMBL4778354 181254 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc2c1 nan
164628435 185708 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1cccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4874254 185708 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1cccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c1 10.1021/acs.jmedchem.1c00820
8036946 182857 2 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4798779 182857 2 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
8036946 182857 2 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4798779 182857 2 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 nan
121349701 181362 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc12 nan
CHEMBL4779884 181362 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc12 nan
121349710 182366 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
CHEMBL4792828 182366 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
121349675 181383 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 4 1 5 3.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
CHEMBL4780038 181383 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 4 1 5 3.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
121349683 182141 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c12 nan
CHEMBL4789720 182141 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c12 nan
121349753 182312 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4792136 182312 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 10.1021/acs.jmedchem.1c00820
121349753 182312 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 nan
CHEMBL4792136 182312 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 nan
78596259 184793 1 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 4 1 5 2.3 CC(NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4860510 184793 1 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 4 1 5 2.3 CC(NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
121349739 181588 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 6 1 6 2.4 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4782619 181588 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 6 1 6 2.4 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)F)cc1 nan
2496250 28739 7 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 338 6 1 6 1.2 COc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL1380104 28739 7 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 338 6 1 6 1.2 COc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349685 181551 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4782204 181551 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349685 181551 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 nan
CHEMBL4782204 181551 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 nan
121349719 182677 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 nan
CHEMBL4796493 182677 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 nan
121349787 182090 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
CHEMBL4789079 182090 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
121349623 181518 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc12 nan
CHEMBL4781805 181518 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc12 nan
121349755 181221 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
CHEMBL4778062 181221 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
121349773 181846 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc2c1 nan
CHEMBL4785980 181846 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc2c1 nan
121349614 181083 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)c(C)c1 nan
CHEMBL4776329 181083 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)c(C)c1 nan
121349720 181661 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(OC)cccc3c2=O)cc1 nan
CHEMBL4783544 181661 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(OC)cccc3c2=O)cc1 nan
121349645 181136 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4776988 181136 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
164611430 184641 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cn1 10.1021/acs.jmedchem.1c00820
CHEMBL4857947 184641 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cn1 10.1021/acs.jmedchem.1c00820
121349746 182802 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4797979 182802 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349746 182802 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
CHEMBL4797979 182802 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
121349745 181630 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 10.1021/acs.jmedchem.1c00820
CHEMBL4783071 181630 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 10.1021/acs.jmedchem.1c00820
121349745 181630 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 nan
CHEMBL4783071 181630 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 nan
8036887 184157 1 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 5 1 5 1.7 C[C@@H](CNC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
CHEMBL4850747 184157 1 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 5 1 5 1.7 C[C@@H](CNC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
121349781 181266 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
CHEMBL4778563 181266 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
121349596 182859 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4798863 182859 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349596 182859 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
CHEMBL4798863 182859 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
121349728 181234 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4778172 181234 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349728 181234 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 nan
CHEMBL4778172 181234 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 nan
121349688 182316 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
CHEMBL4792174 182316 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
27783537 181101 1 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 386 4 1 5 2.4 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Br)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4776509 181101 1 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 386 4 1 5 2.4 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Br)cc1 10.1021/acs.jmedchem.1c00820
121349587 181830 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
CHEMBL4785669 181830 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
121349769 182345 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
CHEMBL4792561 182345 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
121349689 182637 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
CHEMBL4796061 182637 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
121349780 185787 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 5 1 5 1.5 Cc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4875522 185787 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 5 1 5 1.5 Cc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349628 181443 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 10.1021/acs.jmedchem.1c00820
CHEMBL4780801 181443 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 10.1021/acs.jmedchem.1c00820
121349628 181443 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 nan
CHEMBL4780801 181443 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 nan
121349805 182538 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(OC)c3c2=O)cc1 nan
CHEMBL4794908 182538 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(OC)c3c2=O)cc1 nan
27754276 185349 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 5 1 5 2.4 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4869182 185349 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 5 1 5 2.4 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C)cc1 10.1021/acs.jmedchem.1c00820
121349734 181514 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4781729 181514 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 10.1021/acs.jmedchem.1c00820
121349734 181514 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 nan
CHEMBL4781729 181514 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 nan
121349574 182237 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4790968 182237 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 10.1021/acs.jmedchem.1c00820
121349574 182237 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4790968 182237 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 nan
121349569 181333 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
CHEMBL4779481 181333 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
164609046 183903 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.5 Cc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4847108 183903 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.5 Cc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349561 182148 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
CHEMBL4789791 182148 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
121349719 182677 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4796493 182677 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349711 182285 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 358 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)c(F)c1 nan
CHEMBL4791752 182285 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 358 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)c(F)c1 nan
121349694 181633 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 10.1021/acs.jmedchem.1c00820
CHEMBL4783106 181633 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 10.1021/acs.jmedchem.1c00820
121349694 181633 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 nan
CHEMBL4783106 181633 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 nan
121349679 185686 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 6 1 6 1.5 COc1ccc(C[C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4873905 185686 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 6 1 6 1.5 COc1ccc(C[C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349566 182070 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
CHEMBL4788831 182070 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
164621186 185512 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 323 4 0 6 2.4 Cc1ccc([C@H](C)OC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4871591 185512 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 323 4 0 6 2.4 Cc1ccc([C@H](C)OC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349767 182748 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4797410 182748 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349767 182748 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 nan
CHEMBL4797410 182748 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 nan
164620725 185503 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.2 COc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4871506 185503 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.2 COc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349809 182579 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
CHEMBL4795372 182579 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
121349740 181509 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
CHEMBL4781651 181509 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
121349795 182867 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
CHEMBL4798933 182867 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
121349558 181390 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 428 5 1 6 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
CHEMBL4780121 181390 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 428 5 1 6 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
41757362 181631 1 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4783081 181631 1 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
41757362 181631 1 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
CHEMBL4783081 181631 1 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
2144 2324 0 None - 1 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
3313 2324 0 None - 1 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
6140 2324 0 None - 1 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
6925665 2324 0 None - 1 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
CHEMBL301523 2324 0 None - 1 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
DB00120 2324 0 None - 1 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
2780 2341 101 None -630 2 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
6305 2341 101 None -630 2 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
6923516 2341 101 None -630 2 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
717 2341 101 None -630 2 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
CHEMBL54976 2341 101 None -630 2 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
DB00150 2341 101 None -630 2 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
11685 4075 17 None - 1 Human 6.9 pKi = 6.9 Binding
Radioligand competition binding assay using membranes isolated from CHO-T-REx cells that stably express the hGPR139Radioligand competition binding assay using membranes isolated from CHO-T-REx cells that stably express the hGPR139
Guide to Pharmacology 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 34260228
121349608 4075 17 None - 1 Human 6.9 pKi = 6.9 Binding
Radioligand competition binding assay using membranes isolated from CHO-T-REx cells that stably express the hGPR139Radioligand competition binding assay using membranes isolated from CHO-T-REx cells that stably express the hGPR139
Guide to Pharmacology 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 34260228
CHEMBL4779773 4075 17 None - 1 Human 6.9 pKi = 6.9 Binding
Radioligand competition binding assay using membranes isolated from CHO-T-REx cells that stably express the hGPR139Radioligand competition binding assay using membranes isolated from CHO-T-REx cells that stably express the hGPR139
Guide to Pharmacology 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 34260228
2548547 2118 39 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 5 2 2 2.9 O=C(N[C@H](c1ccccc1)C)CNC(=O)c1cccc(c1)Cl 26349500
8766 2118 39 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 5 2 2 2.9 O=C(N[C@H](c1ccccc1)C)CNC(=O)c1cccc(c1)Cl 26349500
CHEMBL3633720 2118 39 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 5 2 2 2.9 O=C(N[C@H](c1ccccc1)C)CNC(=O)c1cccc(c1)Cl 26349500